Department of Emergency Medicine, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.
Resuscitation. 2013 May;84(5):651-6. doi: 10.1016/j.resuscitation.2012.10.024. Epub 2012 Nov 20.
Despite advancements in management of cardiac arrest, mortality remains high and few severity of illness scoring systems have been calibrated in this population. The goal of the current investigation was to assess the Acute Physiology and Chronic Health Evaluation II score in post-cardiac arrest.
This is a prospective observational study of adult post-cardiac arrest patients at a tertiary-care center. The primary outcome variable was in-hospital mortality and secondary outcome variable was neurologic outcome. APACHE II scores were used to predict outcomes using logistic modeling.
A total of 228 subjects were included in the analysis. The median age of the cohort was 70 (IQR: 64-71) and 32% (72/228) of the patients were female. The median downtime was 15 min (IQR: 7-27) and initial lactate 5.9 mmol/L (IQR: 3.5-8.4). 71 (57%) of deaths occurred prior to the 72-h follow-up and overall in-hospital mortality was 55% (125/228). Discrimination of APACHE II score in all cardiac arrest patients increased in stepwise fashion from 0-h to 72-h follow-up (AUC: 0-h: 0.62; 24-h: 0.75; 48-h: 0.82; 72-h: 0.86).
APACHE II score is a poor predictor of outcome at time zero for out-of-hospital cardiac arrest (OHCA) post-arrest patients consistent with the original development of the score in the critically ill. For in-hospital cardiac arrest (IHCA) at time zero and for both IHCA and OHCA at 24h and beyond, the APACHE II score was a modest indicator of illness severity and predictor of mortality/neurologic morbidity.
尽管心脏骤停的治疗已有进展,但死亡率仍然很高,且很少有疾病严重程度评分系统在该人群中得到校准。本研究旨在评估心脏骤停后患者的急性生理学和慢性健康评估 II 评分。
这是一项对三级医疗中心成年心脏骤停后患者的前瞻性观察性研究。主要结局变量是院内死亡率,次要结局变量是神经结局。使用逻辑模型的 APACHE II 评分预测结局。
共纳入 228 名患者进行分析。队列的中位年龄为 70 岁(IQR:64-71),32%(72/228)的患者为女性。中位数停机时间为 15 分钟(IQR:7-27),初始乳酸值为 5.9mmol/L(IQR:3.5-8.4)。71 例(57%)死亡发生在 72 小时随访之前,总院内死亡率为 55%(125/228)。APACHE II 评分在所有心脏骤停患者中的区分度在从 0 小时到 72 小时随访的逐步增加(AUC:0 小时:0.62;24 小时:0.75;48 小时:0.82;72 小时:0.86)。
APACHE II 评分在心脏骤停后(OHCA)患者的零时是预后的不良预测指标,与该评分在危重病患者中的原始开发一致。对于院内心脏骤停(IHCA)的零时,以及 IHCA 和 OHCA 在 24 小时及以后,APACHE II 评分是疾病严重程度的适度指标,也是死亡率/神经功能障碍的预测指标。